3 unknown, 1 active not recruiting. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Unknown 3, Active not recruiting 1 |
Follow Aclarubicin: new trials by email Literature Review of Aclarubicin trials Research Report on Aclarubicin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PD-1 Inhibitors +Venetoclax+CAG Regimens in R/R T-ALL PD-1 Inhibitors - Acute T Lymphoblastic Leukemia (T-ALL) | Phase 3 | Active not recruiting | Fujian Medical University Union Hospital | 40 | 2025-05-01 | 2026-04-21 |
| Dual Growth Factor (rhTPO + G-CSF) and Chemotherapy Combination Regimen in Acute Myeloid Leukemia: Study Protocol for a Randomized Controlled Trial rhTPO, Decitabine - Acute Myeloid Leukemia | Phase 3 | Unknown | Huihan Wang | 130 | 2022-01-21 | 2022-05-19 |
| A Study of SKLB1028 Versus Salvage Chemotherapy in Patients With Relapsed or Refractory (R/R) AML With FLT3-Mutated SKLB1028, Salvage Chemotherapy - Acute Myeloid Leukemia (AML) | Phase 3 | Unknown | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 315 | 2021-03-24 | 2021-11-02 |
| Study of DAC Combined With HAAG Regimen in Newly Diagnosed AML Patients Older Than 60 Decitabine, Homoharringtonine, Aclarubicin, Cytarabine and G-CSF - Acute Myeloid Leukemia, Induction Chemotherapy | Phase 3 | Unknown | The First Affiliated Hospital of Soochow University | 50 | 2019-04-01 | 2019-09-10 |
Leukemia, Myeloid, Acute (3) · Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (1)
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. (1) · Fujian Medical University Union Hospital (1) · Huihan Wang (1) · The First Affiliated Hospital of Soochow University (1)
China (4)
Shaoyuan Wang, Pro (1) · Xiaowen Tang, Ph.D. (1)